74 related articles for article (PubMed ID: 18172853)
1. Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2.
Nagai T; Kikuchi S; Ohmine K; Miyoshi T; Nakamura M; Kondo T; Furuyama K; Komatsu N; Ozawa K
J Cell Biochem; 2008 May; 104(2):680-91. PubMed ID: 18172853
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.
Tarumoto T; Nagai T; Ohmine K; Miyoshi T; Nakamura M; Kondo T; Mitsugi K; Nakano S; Muroi K; Komatsu N; Ozawa K
Exp Hematol; 2004 Apr; 32(4):375-81. PubMed ID: 15050748
[TBL] [Abstract][Full Text] [Related]
3. Hemin counteracts the repression of Bcl-2 and NrF2 genes and the cell killing induced by imatinib in human Bcr-Abl(+) CML cells.
Bonovolias ID; Tsiftsoglou AS
Oncol Res; 2009; 17(11-12):535-47. PubMed ID: 19806784
[TBL] [Abstract][Full Text] [Related]
4. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
Tahara T; Sun J; Igarashi K; Taketani S
Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic characterisation and proteomic profiling of the Imatinib-resistant cell line KCL22-R.
Rosenhahn J; Weise A; Michel S; Hennig K; Hartmann I; Schiefner J; Schubert K; Liehr T; von Eggeling F; Loncarevic IF
Int J Oncol; 2007 Jul; 31(1):121-8. PubMed ID: 17549412
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH
Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346
[TBL] [Abstract][Full Text] [Related]
9. Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
Puttini M; Redaelli S; Moretti L; Brussolo S; Gunby RH; Mologni L; Marchesi E; Cleris L; Donella-Deana A; Drueckes P; Sala E; Lucchini V; Kubbutat M; Formelli F; Zambon A; Scapozza L; Gambacorti-Passerini C
Haematologica; 2008 May; 93(5):653-61. PubMed ID: 18367480
[TBL] [Abstract][Full Text] [Related]
10. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.
Lavallard VJ; Pradelli LA; Paul A; Bénéteau M; Jacquel A; Auberger P; Ricci JE
Cancer Res; 2009 Apr; 69(7):3013-20. PubMed ID: 19318579
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
Kominsky DJ; Klawitter J; Brown JL; Boros LG; Melo JV; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2009 May; 15(10):3442-50. PubMed ID: 19401345
[TBL] [Abstract][Full Text] [Related]
12. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines.
Rumpold H; Wolf AM; Gruenewald K; Gastl G; Gunsilius E; Wolf D
Exp Hematol; 2005 Jul; 33(7):767-75. PubMed ID: 15963852
[TBL] [Abstract][Full Text] [Related]
15. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib.
Ott I; Abraham A; Schumacher P; Shorafa H; Gastl G; Gust R; Kircher B
J Inorg Biochem; 2006 Nov; 100(11):1903-6. PubMed ID: 16908070
[TBL] [Abstract][Full Text] [Related]
17. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
18. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
20. Proteasome proteolytic profile is linked to Bcr-Abl expression.
Crawford LJ; Windrum P; Magill L; Melo JV; McCallum L; McMullin MF; Ovaa H; Walker B; Irvine AE
Exp Hematol; 2009 Mar; 37(3):357-66. PubMed ID: 19157685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
